Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Tiomolibdate Choline

    DEVELOPMENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Atn-224, 649749-10-0, Atn 224, Bis-choline tetrathiomolybdate, Tiomolibdate choline, Tiomolibdate choline [usan]
    Molecular Formula
    C10H30MoN2O2S4
    Molecular Weight
    434.6  g/mol
    InChI Key
    FSWNJZRQQVVVJT-UHFFFAOYSA-L
    FDA UNII
    FD57A79R4P
    Tiomolibdate Choline is an orally active second generation tetrathiomolybdate analog with anti-angiogenic and antineoplastic activities. Tiomolibdate choline selectively chelates the copper ion in superoxide dismutase 1 (SOD1) in endothelial cells, thereby depleting SOD1 of copper and inhibiting its activity. Inhibition of SOD1 interferes with the activation of several signal transduction pathways required for cellular proliferation and angiogenesis, including those mediated by ERK1/2 and FAK and Src kinases. This results in an inhibition of cell proliferation and angiogenesis as well as induction of apoptosis.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    bis(sulfanylidene)molybdenum;2-hydroxyethyl(trimethyl)azanium;sulfanide
    2.1.2 InChI
    InChI=1S/2C5H14NO.Mo.2H2S.2S/c2*1-6(2,3)4-5-7;;;;;/h2*7H,4-5H2,1-3H3;;2*1H2;;/q2*+1;;;;;/p-2
    2.1.3 InChI Key
    FSWNJZRQQVVVJT-UHFFFAOYSA-L
    2.1.4 Canonical SMILES
    C[N+](C)(C)CCO.C[N+](C)(C)CCO.[SH-].[SH-].S=[Mo]=S
    2.2 Other Identifiers
    2.2.1 UNII
    FD57A79R4P
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Ammonium Tetrathiomolybdate

    2. Atn-224

    3. Tetrathiomolybdate

    4. Tetrathiomolybdate Bis-choline Salt

    5. Tetrathiomolybdate, Dipotassium Salt

    6. Tetrathiomolybdate, Disodium Salt

    7. Thiomolybdate

    8. Ttm Cpd

    2.3.2 Depositor-Supplied Synonyms

    1. Atn-224

    2. 649749-10-0

    3. Atn 224

    4. Bis-choline Tetrathiomolybdate

    5. Tiomolibdate Choline

    6. Tiomolibdate Choline [usan]

    7. Alxn1840

    8. Fd57a79r4p

    9. Wtx-101

    10. 2-hydroxy-n,n,n-trimethylethan-1-aminium Tetrathiomolybdate

    11. Unii-fd57a79r4p

    12. Choline Tetrathiomolybdate

    13. Schembl3785098

    14. Wtx101

    15. Alxn-1840

    16. Tiomolibdate Choline [jan]

    17. Hy-16074

    18. Bis(choline) Tetrathiomolybdate [who-dd]

    19. Q17005864

    20. 2-hydroxy-n,n,n-trimethylethanaminium Tetrathiomolybdate

    21. Ethanaminium, 2-hydroxy-n,n,n-trimethyl-, (t-4)-tetrathioxomolybdate(2-) (2:1)

    22. Ethanaminium, 2-hydroxy-n,n,n-trimethyl-, (t-4)-tetrathioxomolybdate(2-)(2:1)

    2.4 Create Date
    2007-12-04
    3 Chemical and Physical Properties
    Molecular Weight 434.6 g/mol
    Molecular Formula C10H30MoN2O2S4
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count4
    Exact Mass436.024417 g/mol
    Monoisotopic Mass436.024417 g/mol
    Topological Polar Surface Area107 Ų
    Heavy Atom Count19
    Formal Charge0
    Complexity65.7
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count5
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of Wilson Disease

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Angiogenesis Inhibitors

    Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)

    Chelating Agents

    Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)

    Enzyme Inhibitors

    Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)